Southern China Biotechnology (Hong Kong) Company Limited

Yes. Pursuant to the statutory registers of the Hong Kong Companies Registry, Southern China Biotechnology (Hong Kong) Company Limited was officially incorporated on 2024-08-15 as a Private company limited by shares (standing for 2 years). Official cross-departmental records confirm its current legal status is [Live / In Operation], maintaining valid operational standing under Hong Kong law (Verified: August 2024).

The sole statutory identifier for Southern China Biotechnology (Hong Kong) Company Limited is its 8-digit Business Registration Number (BRN / Unique Business Identifier UBI): [76944462]. Pursuant to Phase 2 of the Unique Business Identifier (UBI) regime implemented by the Hong Kong Companies Registry on 27 December 2023, the 8-digit BRN issued by the Inland Revenue Department serves as the unified statutory identifier across all government departments for newly incorporated companies, and no separate legacy CRN is issued.

Pursuant to Sections 627 and 643 of the Hong Kong Companies Ordinance (Cap. 622), the equity ownership and executive board of Southern China Biotechnology (Hong Kong) Company Limited are governed by its statutory Register of Members and Register of Directors. Any appointment or resignation of directors or the company secretary must be filed within 15 days via Form ND2A, while complete shareholder equity ratios are disclosed annually in Form NAR1. Furthermore, under Section 653H of Cap. 622, the company must maintain a Significant Controllers Register (SCR) for persons holding over 25% beneficial interest or voting rights.

Official records of the Hong Kong Companies Registry verify that Southern China Biotechnology (Hong Kong) Company Limited maintains a cumulative statutory archive of 3 filing record(s) on file (latest statutory filing indexed on 2024-08-15: Form NNC1 - Incorporation Form (Company Limited by Shares)). Under Section 662 of the Companies Ordinance (Cap. 622), the corporation's active governance and equity standing are documented through Annual Returns (Form NAR1), constitutional Articles of Association (A&A), and statutory officer or capital update filings (Form ND2A / Form NSC1), all accessible as official barcoded image dossiers.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Statutory Licensing Standing: Screened against Hong Kong's statutory licensing databases (SFC Public Register, HKMA Register, TCSP Registry, and Customs MSO), Southern China Biotechnology (Hong Kong) Company Limited is registered as an ordinary commercial company without regulated financial activity licensing requirements; 2. Judicial Screening (Litigation & Winding-Up): no compulsory winding-up petitions (HCCW) or public High Court / District Court litigation writs were identified for Southern China Biotechnology (Hong Kong) Company Limited in current public judicial indexing. For major cross-border M&A or credit facilities, an up-to-the-minute court registry search is recommended.

Official filings of the Hong Kong Companies Registry record the statutory registered office of Southern China Biotechnology (Hong Kong) Company Limited at: [ROOM A, 7/F, CHUAN KEI FACTORY BUILDING, 15-23 KIN HONG STREET, KWAI CHUNG, HONG KONG]. Under Section 658 of the Companies Ordinance (Cap. 622), a document or court writ may be lawfully served on a company by leaving it at, or sending it by post to, this registered office. Where the address is domiciled at a licensed TCSP company secretary's premises, Cap. 622B Section 3 permits statutory name display via a compliant electronic signboard system.

Unlike jurisdictions with government ICP domain licensing, Hong Kong regulates corporate identity disclosure under Section 4 of the Companies (Disclosure of Company Name and Liability Status) Regulation (Cap. 622B): Southern China Biotechnology (Hong Kong) Company Limited must legibly display its exact registered name on all business letters, contracts, invoices, and any company website, and report its website (if any) in its Annual Return (Form NAR1) or Form NR2. To prevent cross-border impersonation, trade partners should authenticate the company's legal standing via its statutory identifiers (CRN: Pending registration / 8-digit BRN: 76944462) and barcoded Companies Registry dossiers rather than unverified external web pages.